In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy.
Seth J RotzNathan LuebberingBradley P DixonEugenia GkaliagkousiRobert A BrodskyChristopher E DandoySonata JodeleStella M DaviesPublished in: Blood advances (2017)
Transplantation-associated thrombotic microangiopathy is associated with complement activation in vitro.This data further supports the use of eculizumab for the treatment of patients with TA-TMA.